Communications 11th

Communications

 
Pierre Drouin lecture
Simon D. (France)
Slide set

Friday 24th April, 2009
SYMPOSIUM A: “Acute and long-term management of type 1 diabetes”

New pharmacological approaches to type 1 diabetes treatment
Boitard C. (France)
Abstract

Optimising glycaemic control and quality of life in patients with type 1 diabetes mellitus
Vassallo J. (Malta)
Abstract

Elevated total adiponectin levels are independent of sex, adiposity and renal function in normoalbuminuric normotensive patients with type I diabetes; but dependant of diabetes duration and control
Abi-Khalil C. (France)
Abstract

Impact des variations allèliques de la superoxyde dismutase 1 dans le développement et la progression de la néphropathie diabétique dans trois cohortes de sujets diabétiques de type 1
Mohammedi K. (France)
Abstract

Etude comparative du diabète de type 1a et du diabète de type 1b chez les jeunes diabetiques avec cétose inaugurale
Slim I. (Tunisia)
Abstract

SYMPOSIUM B: “Brain and diabetes”

Evidence on the comorbidity of depression and diabetes
Driss Moussaoui. (Morocco)
Abstract

Cognitive impairment and diabetes
Maggi S. (Italy)
Abstract

Impact of metabolic disorders on brain
Maran A. (Italy)

Pathologie cérébro-vasculaire chez le diabétique âgé : à propos de 72 cas
Hannat S. (Algeria)
Abstract
Slide set

Diabetes and depressive symptomatology among elderly Italians. The Italian longitudinal study on aging
Limongi F. (Italy)
Abstract

SYMPOSIUM C: “From science to cost effectiveness”

How to measure cost effectiveness in diabetes in the mediterranean area
Williams R. (United Kingdom)
Abstract

Cost effectiveness of a team approach to diabetic foot management
Gonçalves A.L., Gardete-Correia L. (Portugal)
Abtsract

Quality of life improves after patients switch to novomix® 30 (biphasic insulin aspart 30/70): improve™ study data from 39,015 patients
Benroubi M. (Greece)
Abstract
Slide set

Diabetes prevention in the Mediterranean region: the med_plan project
Barengo N.C. (Spain)
Abstract
Slide set

Prevalence of people at high risk of Type 2 diabetes in two population settings in madrid, Spain 2007 within the PREDIMERC and the DE_plan studies
Gabriel R. (Spain)
Abstract
Slide set

Saturday 25th April, 2009
SYMPOSIUM D: “Clinical cases and application of guidelines in type 2 diabetes”

Cardiovascular disease and diabetes in Malta
Fava S. (Malta)
Abstract
Slide set

SYMPOSIUM E: “Prevention of vascular events in type 2 diabetic patients”

Onset of vascular complications in type 2 diabetes: Continuum or threshold
Rovira-Loscos A. (Spain)
Abstract

The ADVANCE trial: rationale, design, results of the blood pressure lowering arm”
Mancia G. (Italy)
Abstract

Etude ADVANCE : Resultats Du Bras Controle Glycemique
Marre M. (France)
Abstract

Impact of landmark clinical trials in daily practice
Hadjadj S. (France)

SYMPOSIUM F: “How to evaluate the glycemic control: what are the best tools?”

Self glucose monitoring in type 1 and 2 diabetes
Malek R. (Algeria)
Abstract
Slide set

Translating the A1c to Estimate Average Glycemia(eAG)
Albache N. (Syria)
Abstract

Post prandial glycemia and cardiovascular complications
Cavallo Perin P. (italy)
Abstract

Transient interstitial glucose monitoring improves glycaemic control
Alves M. (Portugal)
Abstract
Slide set

Significant thresholds for the 75g OGTT in pregnancy
Vella K. (Malta)
Abstract

Final lecture

Balancing needs & means: the dilemma of the pancreatic. Beta cell in the modern world
Cerasi E. (Israël)
Abstract